SCHEMBL19976787

SCHEMBL19976787

CC(C)(O)CN/C(=N/C(=O)c1cccc(Cl)c1)Nc1n[nH]c2cc(F)ccc12

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.43
MAPK8 P45983 1/20 0.42
MAPK10 P53779 1/20 0.42
GSK3B P49841 8/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
GSK3A P49840 1/20 0.40
MAP2K4 P45985 3/20 0.40
CYP1A2 P05177 2/20 0.39
FGFR1 P11362 2/20 0.38
FGFR2 P21802 2/20 0.38
FGFR4 P22455 2/20 0.38
FGFR3 P22607 2/20 0.38
MAP2K7 O14733 1/20 0.38
FADS1 O60427 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976859 0.90 GSK3B (0.45) HDAC6GSK3BGSK3AMAP2K4CYP1A2
SCHEMBL16769264 0.90 HDAC6 (0.45) HDAC6MAPK8MAPK10GSK3BHDAC1
SCHEMBL16752836 0.90 HDAC6 (0.45) HDAC6MAPK8MAPK10GSK3BHDAC1
SCHEMBL16752833 0.90 HDAC6 (0.45) HDAC6MAPK8MAPK10GSK3BHDAC1
SCHEMBL19976886 0.89 GSK3B (0.43) HDAC6GSK3BGSK3AMAP2K4CYP1A2
SCHEMBL19976820 0.88 HDAC6 (0.46) HDAC6MAPK8MAPK10GSK3BHDAC1
SCHEMBL19976821 0.87 HDAC6 (0.44) HDAC6MAPK8MAPK10GSK3BHDAC1
SCHEMBL19976741 0.86 MAPK1 (0.44) HDAC6MAPK8MAPK10GSK3BHDAC1
SCHEMBL19976744 0.86 GSK3B (0.45) HDAC6GSK3BGSK3AMAP2K4CYP1A2
SCHEMBL19976888 0.79 GSK3B (0.51) HDAC6MAPK8MAPK10GSK3BHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed